Saeko Arai
Directeur/Membre du Conseil chez SUMITOMO PHARMA CO., LTD.
Provenance du réseau au premier degré de Saeko Arai
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Real Estate Development | 24 | |
| Public Company | Pharmaceuticals: Major | 23 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Saeko Arai via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Tokyu Land Corp.
 Tokyu Land Corp. Real Estate DevelopmentFinance Tokyu Land Corp. engages in the property development industry. It operates through the following segments: Real Estate Sales, Contracted Construction, Retail Sales, Leasing of Real Estate, Property Management, Facility Operations, Real-estate Agents, and Other. The Real Estate Sales segment provides the development and sale of condominiums, housing, and buildings. The Contracted Construction segment establishes and renovates high-rise residential and detached houses. The Retail Sales segment conducts retail sales of living products and do-it-yourself materials. The Leasing of Real Estate segment handles apartments, shopping centers, office buildings, and hotels for rent. The Property Management segment deals with general administration of buildings and condominiums. The Facility Operations segment manages and develops golf courses, resort-hotel membership, ski resorts, fitness clubs, and senior citizen housing. The Real Estate Agents segment serves as property sales representatives. The Other segment commissions business appraisals through its subsidiaries. The company was founded on December 17, 1953 and is headquartered in Tokyo, Japan. | Real Estate Development | Chairman Comptroller/Controller/Auditor Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director of Finance/CFO Corporate Officer/Principal Comptroller/Controller/Auditor President | |
Tokyu Livable, Inc.
 Tokyu Livable, Inc. Real Estate DevelopmentFinance Tokyu Livable Inc. engages in the purchase, sale, leasing and brokerage of real estate properties. It operates through the following segments: Sales Agency, Real Estate Sales, Purchase or Sale Brokerage, Real Estate Solutions, Rental Brokerage and Others. The Sales Agency segment engages in the sale of new residential lots, condominiums and houses. The Real Estate Sales segment engages in the sale of condominiums lots and detached houses. The Purchase or Sale Brokerage segment provides services tailored to the needs of each individual customers. The Real Estate Solutions segment provides brokerage and advisory services, business recovery assistance, auction management, real estate purchase and capital investment, asset valuation and surveys; and asset management services. The Rental Brokerage segment provides support services to the facilitate rental management with various options for the owners. The Others segment includes equity and investment, insurance agency and real estate appraisal businesses. The company was founded on March 10, 1972 and is headquartered in Tokyo, Japan. | Real Estate Development | Chairman Director/Board Member Chairman Director/Board Member Director/Board Member President President Comptroller/Controller/Auditor | |
Tokyu Community Corp.
 Tokyu Community Corp. Real Estate DevelopmentFinance Tokyu Community Corp. provides property management services for condominiums and office buildings. Its services include building management, life support, community development support, renovation, repairs, and energy conservation. The company was founded on April 8, 1970 and is headquartered in Tokyo, Japan. | Real Estate Development | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Tokyu Hands, Inc.
 Tokyu Hands, Inc. Department StoresRetail Trade Part of Tokyu Fudosan Holdings Corp., Tokyu Hands, Inc. operates a chain of department stores. The company is based in Tokyo, Japan. | Department Stores | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Tokyu Housing Lease Corp.
 Tokyu Housing Lease Corp. Real Estate DevelopmentFinance Part of Tokyu Fudosan Holdings Corp., Tokyu Housing Lease Corp. is a real estate asset management company based in Tokyo, Japan. The Japanese company integrates various rental housing operations such as Tokyu Livable, Tokyu Community, Tokyu Relocation Rental Housing Operation, and Company House Agency to support the operation management of rental properties. The company's corporate philosophy is to contribute to society through the real estate business by understanding the needs of clients and providing the highest level of service. The company is an innovation partner for asset management, mainly for real estate investment such as rental management. | Real Estate Development | Director/Board Member Chairman President Director/Board Member Comptroller/Controller/Auditor | |
National Students Information Center Co., Ltd.
 National Students Information Center Co., Ltd. Real Estate DevelopmentFinance National Students Information Center KK engages in the business of managing and supporting condominium services for students. It also engages in tenant recruitment and resident services. The company was founded in 1975 and is headquartered in Kyoto, Japan. | Real Estate Development | Director/Board Member Director/Board Member Comptroller/Controller/Auditor Director/Board Member | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| TOKYU CORPORATION | Other Transportation | Director/Board Member Director/Board Member Chairman | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TOKYU RECREATN | Movies/Entertainment | Director/Board Member Director/Board Member | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member | |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Tokyu Homes Corp. | Director/Board Member Director/Board Member | ||
| MORINAGA&CO., LTD. | Food: Specialty/Candy | Director/Board Member | |
| RESONA HOLDINGS, INC. | Regional Banks | Director/Board Member | |
| SAN-A CO.,LTD. | Food Retail | Director/Board Member | |
| GURUNAVI, INC. | Internet Software/Services | Director/Board Member | |
| National Police Agency | General Government | Director/Board Member | |
| NIPPON TELEGRAPH AND TELEPHONE CORPORATION | Major Telecommunications | Chairman | |
Resona Bank Ltd.
 Resona Bank Ltd. Regional BanksFinance Resona Bank, Ltd. provides commercial banking services. It operates through the following segments: Personal, Corporate, and Market. The Personal segment handles financial services for individual customers including personal loans, asset management, and inherited asset consulting. The Corporate segment focuses on lending, asset management that uses trusts, real estate operations, enterprise pensions, and business growth support. The Market segment engages in funds, foreign and local exchanges, bonds, and derivatives. It also offers current and savings accounts, mortgages, debit and credit cards, pension and insurance products, online and phone banking, and investment trusts. The company was founded on May 15, 1918 and is headquartered in Osaka, Japan. | Regional Banks | Director/Board Member | |
| LIXIL CORPORATION | Building Products | Director/Board Member | |
Tolero Pharmaceuticals, Inc.
 Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT. | Pharmaceuticals: Other | Director/Board Member | |
Primetals Technologies Ltd.
 Primetals Technologies Ltd. Information Technology ServicesTechnology Services Primetals Technologies Ltd. operates as a engineering and plant construction company. It manures of steel and iron products. The company was founded in January 2015 and is headquartered in London, the United Kingdom. | Information Technology Services | Director of Finance/CFO | |
Nihon Medi-Physics Co., Ltd.
 Nihon Medi-Physics Co., Ltd. Pharmaceuticals: MajorHealth Technology Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura. | Pharmaceuticals: Major | Chief Executive Officer | |
Sunovion Pharmaceuticals Europe Ltd.
 Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | Pharmaceuticals: Major | Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
TFHD Open Innovation Program
 TFHD Open Innovation Program Investment ManagersFinance TFHD Open Innovation Program is a Venture Capital arm of Tokyu Fudosan Holdings Corp. (TK:3289) founded in 2017. The firm is headquartered in Tokyo. | Investment Managers | President | |
| Graduate School of Economics, Keio University | College/University | Undergraduate Degree | |
| University of Tokyo | College/University | Undergraduate Degree | |
| foundation for the Fusion of Science & Technology | Director/Board Member | ||
| SENSHUKAI CO., LTD. | Internet Retail | Director/Board Member | |
| Financial Services Agency | General Government | Corporate Officer/Principal | |
| AISIN CORPORATION | Auto Parts: OEM | Director/Board Member | |
General Insurance Association of Japan
 General Insurance Association of Japan Multi-Line InsuranceFinance General Insurance Association of Japan provides insurance services. Its activities include enhancing the dissemination and understanding of general insurance, responding to consultation, complaints and disputes, improving the quality of insurance business administration and maintaining and improving the business environment of general insurance. The company was founded in 1946 and is headquartered in Tokyo, Japan. | Multi-Line Insurance | Director/Board Member | |
Dentsu International Ltd.
 Dentsu International Ltd. Advertising/Marketing ServicesCommercial Services Dentsu International Ltd. engages in the provision of media advertising and digital communications services. It offers digital creative execution, content creation, media planning, sports, entertainment marketing and search engine optimization strategy, near-field communications, and marketing analytics. The company was founded on December 5, 1978 and is headquartered in London, the United Kingdom. | Advertising/Marketing Services | Director/Board Member | |
| DENTSU INC. | Advertising/Marketing Services | Director/Board Member | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | Director/Board Member | |
| FUJIFILM HOLDINGS CORPORATION | Medical Specialties | Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
| Hiroshima University | College/University | Doctorate Degree | |
Meltin MMI KK
 Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| DAIWA SECURITIES GROUP INC. | Investment Banks/Brokers | Director/Board Member | |
| Pancreas Research Foundation of Japan | Chairman | ||
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Japon | 38 |
| Etats-Unis | 8 |
| Royaume-Uni | 6 |
| Bermudes | 2 |
Sectorielle
| Health Technology | 15 |
| Finance | 12 |
| Consumer Services | 5 |
| Retail Trade | 4 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 159 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 37 |
| President | 30 |
| Chairman | 23 |
Relations les plus connectées
- Bourse
- Insiders
- Saeko Arai
- Connexions Sociétés
